Home › Multiple Sclerosis › Maryland
Pag-aaral pangklinika para sa Multiple Sclerosis sa Maryland
17 pag-aaral para sa Multiple Sclerosis ang naghahanap ng mga kalahok sa mga site sa Maryland.
Mga Lungsod sa Maryland
Opisyal na teksto ng pag-aaral (English)
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Baltimore
- TG Therapeutics Investigational Trial Site, Glen Burnie
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06433752Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
1 Month – 99 Years · Lahat ng kasarian · Na-update Set 22, 2026 · NCT00794352Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT00001248Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 2
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT02784210Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Baltimore Veterans Affairs Medical Center- Site Number : 8400163, Baltimore
Nagre-recruitPhase 3
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07325292RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Sunstone Therapies, PC, Rockville
- Sheppard Pratt, Towson
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07002034Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 120 · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT01730131Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 1/2
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT03109288A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Mid Atlantic Epilepsy and Sleep Ctr, Bethesda
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT07225504Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
- Johns Hopkins University, Baltimore
Nagre-recruitPhase 2
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Hul 17, 2026 · NCT07497399Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
- Johns Hopkins University, Baltimore
Nagre-recruitPhase 2
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Hun 9, 2026 · NCT06170970Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Hun 5, 2026 · NCT05849467Pathological Basis of MRI Signal Changes in Multiple Sclerosis
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Hun 5, 2026 · NCT02659956Genes and Environment in Multiple Sclerosis
- National Institute of Neurological Disorders and Stroke, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update May 14, 2026 · NCT01353547Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis
- Johns Hopkins University, Baltimore
Nagre-recruitPhase 4
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update May 6, 2026 · NCT07389590A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
- Evidera INC., Bethesda
- Evidera, Bethesda
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Kababaihan · Na-update Nob 20, 2025 · NCT05170126Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.